Domů › Kolorektální karcinom › Kalifornie › Santa Monica
Klinické studie Kolorektální karcinom v Santa Monica, CA
23 studií pro Kolorektální karcinom hledá účastníky v lokalitách v Santa Monica a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Probíhá náborFáze 2
- Tower Cancer Research Foundation, Beverly Hills · Vzdálenost 6 mi
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Probíhá náborFáze 1
- ALX Center 11, Santa Monica
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Probíhá náborFáze 1
- Research Site, Santa Monica
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Probíhá náborFáze 2
- UCLA - Santa Monica /ID# 270621, Santa Monica
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Probíhá náborFáze 3
- UCLA, Santa Monica
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Probíhá náborObservační studie
- UCLA Medical Center, Santa Monica
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Probíhá náborFáze 3
- UCLA, Santa Monica
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Probíhá náborFáze 1/2
- Precision NextGen Oncology, Beverly Hills · Vzdálenost 6 mi
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- Kivu Trial Site, Santa Monica
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Probíhá náborFáze 1
- University of California, Los Angeles (UCLA), Santa Monica
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Probíhá náborFáze 3
- Clinical Study Site, Beverly Hills · Vzdálenost 6 mi
- Clinical Study Site, Beverly Hills · Vzdálenost 6 mi
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Probíhá náborFáze 1
- University of California, Los Angeles (UCLA), Santa Monica
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Sarcoma Oncology Center, Santa Monica
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Probíhá náborFáze 1/2
- GSK Investigational Site, Santa Monica
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Probíhá náborFáze 1
- UCLA Healthcare Hematology-Oncology, Santa Monica
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Probíhá náborFáze 2
- UCLA Medical Center, Santa Monica
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Probíhá náborFáze 1
- Sarcoma Oncology Center, Santa Monica
- Precision NextGen Oncology and Research Center, Beverly Hills · Vzdálenost 6 mi
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Probíhá náborFáze 2
- UCLA Hematology/Oncology-Santa Monica, Santa Monica
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Probíhá náborFáze 1
- UCLA Santa Monica Hematology Oncology, Santa Monica
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Probíhá náborFáze 1/2
- UCLA, Santa Monica
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
Probíhá náborObservační studie
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · Vzdálenost 4 mi
A Beta-only IL-2 ImmunoTherapY Study
Probíhá náborFáze 1/2
- Providence Saint John's Health Center, Santa Monica
Urine Metabolites in the Diagnosis of Disease
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Digestive Health Associates, Santa Monica
- Westside Gastro Care, Santa Monica
Studie Kolorektální karcinom v jiných městech
- Houston, TX102 studií
- New York City, NY78 studií
- Nashville, TN69 studií
- Boston, MA63 studií
- Los Angeles, CA59 studií
- Arlington, VA52 studií
- St. Louis, MO50 studií
- San Antonio, TX46 studií
- Philadelphia, PA44 studií
- Grand Rapids, MI40 studií
- Baldwin Park, CA37 studií
- Chicago, IL34 studií
Další studie v Santa Monica
- Nemalobuněčný plicní karcinom45 studií
- Rakovina prsu28 studií
- Rakovina (všechny typy)22 studií
- Metastatický karcinom19 studií
- Rakovina plic15 studií
- Rakovina vaječníků15 studií
- Rakovina prostaty15 studií
- Squamózní buněčný karcinom hlavy a krku13 studií
- Srdeční selhání11 studií
- Rakovina endometria10 studií
- Rakovina žaludku9 studií
- Rakovina slinivky břišní9 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.